UNSW Banner

UNSW Embryology

Abnormal Development - Radiation

© Dr Mark Hill (2009)

Acknowledgements

Introduction

This page introduces the possible effects of radiation on development. The two main sources of exposure are environmental and those used for medical diagnostic or therapeutic purposes.

Studies have shown that in maternal X-ray diagnostic examination, where the beam does not irradiate the embryo/fetus directly (maternal skull and chest X-ray), the absorbed dose for the embryo or fetus is extremely low (less than 0.01 mGy).

Treatment of hyperthyroidism with 131 Iodine in a pregnant woman is strictly contraindicated due to the effects on the developing embryonic thyroid gland.

Page Links: Introduction | Some Recent Findings | Diagnostic Radiography | International Commission on Radiological Protection | Dual X-ray Absorptiometry | Herbal Drugs | USA Top 200 Prescriptions | Australian NHMRC Recommendations | Maternal Derived Abnormalities | WWW Links | References | Glossary

Some Recent Findings

Diagnostic Radiography

A recent Australian review study has shown minimal effects of standard diagnostic radiography underspecific conditions.

"The only adverse effect statistically proven at the dose levels associated with diagnostic radiation procedures is a very small increase in childhood malignancy, with an estimated increase of one additional cancer death per 1700 10 mGy exposures. The important exception was the risk to the fetal thyroid from radioiodine exposure after 12 weeks' gestation."

Lowe SA. Diagnostic radiography in pregnancy: risks and reality. Aust N Z J Obstet Gynaecol. 2004 Jun;44(3):191-6.

email Dr S.A. Lowe Department of Medicine, Royal Hospital for Women, New South Wales, Randwick, Sydney, Australia

International Commission on Radiological Protection

"Almost always, if a diagnostic radiology examination is medically indicated, the risk to the mother of not doing the procedure is greater than is the risk of potential harm to the fetus. Most nuclear medicine procedures do not cause large fetal doses. However, some radiopharmaceuticals that are used in nuclear medicine can pose significant fetal risks. It is important to ascertain whether a female patient is pregnant prior to radiotherapy."

"...Fetal doses below 100 mGy should not be considered a reason for terminating a pregnancy."

International Commission on Radiological Protection Pregnancy and medical radiation. Ann ICRP. 2000;30(1):iii-viii, 1-43.

"It should be also remembered that irradiation of the fetus in all trimesters of the pregnancy carries an increased risk of cancer in the newborn in the first or second decade of life and at therapeutic doses - or their significant fraction - this risk can be substantial. Therefore, in view of all mentioned factors termination of pregnancy may be considered. The decision should be based on careful estimation of the entailed risk to the fetus, which in turn requires calculation of the dose to conceptus by a qualified expert. The decision itself should be made by the women to be treated in consultation with their physician, partner and counsellor. Particularly difficult problems arise when radiotherapy is performed in a woman with early, undiagnosed pregnancy. The result is sometimes a massive irradiation of the conceptus in a period when malformations are easily induced (at or after 3 weeks post conception).

To avoid such unintentional irradiation it seems necessary to perform pregnancy tests to diagnose, or exclude the pregnancy before undertaking radiotherapy.

Therapy of hyperthyroidism with 131 Iodine in a pregnant woman is strictly contraindicated due to possibility of external irradiation of the foetus but mostly due to radioactive iodide crossing the placenta into the foetal circulation with subsequent uptake by its thyroid. The gland may well be destroyed by beta radiation from the nuclide taken up (131I). Therefore, other methods of treatment should be employed, if possible, until delivery." (Text extract from: ICRP Radiation and your Patient: A Guide for Medical Practitioners PDF document (17 pages, 142 kB)

Links: International Commission on Radiological Protection | Pregnancy and Pedical Radiation Powerpoint Slide set(1.3 Mb) | Radiation and your Patient: A Guide for Medical Practitioners PDF document (17 pages, 142 kB) |

Dual X-ray Absorptiometry

These types of radiological studies can be carried out in osteoporosis examinations.

"The aim of the current study was to estimate the embryo/fetus radiation doses and risks associated with spinal and hip dual X-ray absorptiometry (DXA) scans performed on the pregnant mother."

"In conclusion, the embryo/fetus dose in bone density measurements of spine and femur using pencil beam DXA is lower than the average daily natural background in the United States of 8 mGy. The health provider can decide whether a DXA scanning is beneficial to a pregnant woman, taking into account the potential radiation risks to the embryo/fetus presented in the current study."

Damilakis J, Perisinakis K, Vrahoriti H, Kontakis G, Varveris H, Gourtsoyiannis N. Embryo/fetus radiation dose and risk from dual X-ray absorptiometry examinations. Osteoporos Int. 2002 Sep;13(9):716-22.

Australian NHMRC Recommendations

The Australian NHMRC (1988) recommends neonates be assessed for follow-up care under the following conditions.

References

Reviews

Lowe SA. Diagnostic radiography in pregnancy: risks and reality. Aust N Z J Obstet Gynaecol. 2004 Jun;44(3):191-6.

International Commission on Radiological Protection Pregnancy and medical radiation. Ann ICRP. 2000;30(1):iii-viii, 1-43.

Timins JK. Radiation during pregnancy. N J Med. 2001 Jun;98(6):29-33.

Articles

Lowe SA. Diagnostic radiography in pregnancy: risks and reality. Aust N Z J Obstet Gynaecol. 2004 Jun;44(3):191-6.

Damilakis J, Perisinakis K, Vrahoriti H, Kontakis G, Varveris H, Gourtsoyiannis N. Embryo/fetus radiation dose and risk from dual X-ray absorptiometry examinations. Osteoporos Int. 2002 Sep;13(9):716-22.

NCBI Bookshelf

Health Services/Technology Assessment Text (HSTAT) Bethesda (MD): National Library of Medicine (US), (2003)

Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV-1 Transmission in the United States

Management of Chronic Hypertension During Pregnancy

Improving Treatment for Drug-Exposed Infants

St. John's Wort

Pregnant, Substance-Using Women

WWW Links

Other Maternal Factors Prenatal

Alcohol "Fetal Alcohol Syndrome"

Smoking

Chemical

Drug Use

Legal Drugs

Folic Acid

Nutrition

Infection

Rubella

Sexually Transmitted Diseases

Syphilis

cytomegalovirus

Iodine Deficiency

Trauma

These links require online access to Merck Manuals on Women's Health Issues. http://www.merck.com/mrkshared/mmanual_home2/sec22/sec22.jsp

Risk Factors Present Before Pregnancy

Risk Factors That Develop During Pregnancy

Diseases that complicate Pregnancy

Problems Affecting the Fetus or Newborn

Heart Disease

Heart Failure

Rheumatic Heart Disease

Birth Defects of Heart

Mitral Valve Prolapse

High Blood Pressure

Anemias

Kidney Disease

Infectious Disease

Diabetes

Thyroid

Liver

Asthma

Systemic Lupus Erythematosus

Rheumatoid Arthritis

Myasthenia Gravis

Idiopathic Thrombocytopenic Purpura

>Surgery During Pregnancy

Maternal derived abnormalities

Relate to lifestyle, environment and nutrition. Some examples of this form of abnormality are the impact of excess alcohol on neural development (Fetal alcohol syndrome), viral infection (rubella) at a critical stage of development, inadequate dietry folate intake (neural tube defects), effects of prescription drugs (Thalidomide- limb development) and even maternal endocrine function (thyroid development).

In addition to these obvious maternally-derived abnormalities, there is growing evidence that the interuterine environment has a strong influence on later postnatal health. This theory is based on the early statistical analysis of disease/longevity in babies with low birth weights in England by Barker, and has been called the "Barker Hypothesis". (More? Barker Hypothesis)

Non-Maternal Postnatal Factors

Sudden Infant Death Syndrome (SIDS)

Malnutrition

Infection

Trauma

Iodine Deficiency

chemical

see also Normal Childhood Development

Congenital abnormalities

These developmental abnormalities usually involve only small DNA mutations affecting individual or a few genes, two exceptions are the major chromosomal abnormalities usualy trisomy; trisomy 21 (Down syndrome) and trisomy 18 (Edwards syndrome) (also trisomy 9, 13, 15). Note that the occurance of chromosomal abnormalities also increases with increasing maternal age. There are many pamphlets providing information about prenatal diagnosis (see NSW State Health Publication Checking your baby's health before birth).

Finally

Each section of the notes covering early development and specific systems contain references to specific abnormalities (on Page 2 of each notes section). The best source for Australian statistical data is the Australian Institute of Health and Welfare National Perinatal Statistics Unit, UNSW which publishes "Congenital Malformations Australia" every 2 years. Be aware that some congenital abnormalities, by their nature, affect multiple systems. In the USA, the Center for Disease Control (CDC) keeps and publishes relevant statistical information. A very difficult issue in abnormal development are the many different Ethical implications.

This current page is a link to Normal and Abnormal Development and Population Data.

Where to Next?

You should look at normal development. Development Notes

Alternatively, go on to look at Systematic Development of organs and tissues.

Glossary of Terms

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Quick Links

Finally

For those wanting to see dynamic processes of development (and have a reasonably quick connection) then the Movies pages are good for watching changes occur.

Other Embryos

The study of human development has relied extensively on studying the process in other model animals. For those wanting to see the process of development in other species then the other embryos pages are a good start.

UNSW Embryology ISBN: 978 0 7334 2609 4

UNSW CRICOS Provider Code No. 00098G